Wael Mekhael

Research Methods II
July11, 2015
References
1. Timmerman R, Kavanagh B, Cho L, Papiez L, Xing L. Stereotactic body radiation therapy in
multiple organ sites. J Clin Oncol. 2007;25(8):947952.
http://dx.doi.org/10.1200/JCO.2006.09.7469
2. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48 Gy of
stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic
body frame. Int J Radiat Oncol Biol Phys. 2005;63(7):14271431.
http://dx.doi.org/10.1016/j.ijrobp.2005.05.034
3. Timmerman R, Papiez L, McGarry R, et al. Extra-cranial stereotactic radio ablation: results
of a phase I study in medically inoperable stage I non-small cell lung
cancer. Chest. 2003;124(5):19461955. http://dx.doi.org/10.1378/chest.124.5.1946
4. Olivier C, Mustapha K, Patrice J, et al. Potential benefits of using non-coplanar field and
intensity modulated radiation therapy to preserve the heart in irradiation of lung tumors in the
middle and lower lobes. Radiother Oncol. 2006;80(3):333-340.
http://dx.doi.org/10.1016/j.radonc.2006.07.009
5. Graham M, Purdy J, Emami B, et al. Clinical dose volume histogram analysis for
pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol
Biol Phys. 1999;45(2):323-329. http://dx.doi.org/10.1016/S0360-3016(99)00183-2